Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV824
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,910
Award facts
- Contract value 100% obligated
- $35,909.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,909.64 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed-price contract with an ultimate completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded without any set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract valued at up to $999,999,999.00 with DLA Troop Support Medical through December 2031. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the delivery of a wide range of medications, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government requirements for pharmaceutical products across multiple therapeutic domains, including diabetes medications, specialty treatments, and other essential medical commodities. This specific delivery order for Zepbound, a diabetes treatment, reflects the company's ongoing role in supplying medications required by the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FV824?
SPE2DR26FV824 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV824 worth?
The government has obligated $35,910 on SPE2DR26FV824.
Is contract SPE2DR26FV824 an order under another contract?
Yes. SPE2DR26FV824 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV824 competed?
The extent of competition for SPE2DR26FV824 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award